Skip to main content

Peter Arduini

Equibles does not estimate personal net worth.

About Peter Arduini

Peter Arduini was last confirmed as CEO and Board Member at Integra Lifesciences Holdings Corp (IART) in a filing dated April 9, 2021. The proxy statement of Integra Lifesciences Holdings Corp reports total compensation of $9,839,221 for Peter Arduini in fiscal 2021, including a base salary of $956,308. Disclosed compensation is on record for 5 fiscal years. Peter Arduini has spoken on 7 earnings calls across 1 company, most recently for Integra Lifesciences Holdings Corp on November 2, 2021. The companies whose calls Peter Arduini spoke on are classified in the Healthcare sector.

Peter Arduini on recent calls

“If you please turn to Slide 5, I'd like to make a few brief remarks regarding the CEO transition. Last Thursday, we issued a press release announcing that after a comprehensive search of candidates, our board has appointed Jan De Witte as its next President and Chief Executive Officer.”
CEO, Integra Lifesciences Holdings Corp Q3 FY2021 Earnings Call ·
“I'm pleased to report strong results this morning, reflecting the continued momentum in the business, which enabled us to raise our full year guidance. If you'll turn to Slide 5 in the deck, I'll begin with a review of our second quarter performance.”
CEO, Integra Lifesciences Holdings Corp Q2 FY2021 Earnings Call ·
“If you turn to Slide 4, I’ll begin with a review of our first quarter performance. Total revenues were $360 million, representing reported growth of 1.6% and organic growth of 2.9% compared to the prior year.”
CEO, Integra Lifesciences Holdings Corp Q1 FY2021 Earnings Call ·
“If you'll turn to slide 4, I'll begin with a review of our performance in 2020. Full year 2020 revenues declined 8.7% on an organic basis to $1.37 billion and adjusted earnings declined 11% to $2.45.”
CEO, Integra Lifesciences Holdings Corp Q4 FY2020 Earnings Call ·
“If you turn to Slide 10, I'd like to start with some comments about the recent announcement to divest our Orthopedics business. On September 29, we announced the signing of a definitive agreement to divest the Extremity Orthopedics business to Smith & Nephew.”
CEO, Integra Lifesciences Holdings Corp Q3 FY2020 Earnings Call ·

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Integra Lifesciences Holdings Corp (IART) $956,308 $9,839,221
2020 Integra Lifesciences Holdings Corp (IART) $848,077 $7,740,699
2019 Integra Lifesciences Holdings Corp (IART) $975,000 $7,859,423
2018 Integra Lifesciences Holdings Corp (IART) $947,916 $7,647,812
2017 Integra Lifesciences Holdings Corp (IART) $905,024 $7,134,568

Recent activity